Altre lingue Welcure Drugs & Pharmaceuticals Limited

Azioni

WELCURE6

INE331C01017

Mercato chiuso - Bombay S.E. Altri mercati azionari 12:00:53 03/05/2024			Variaz. 5gg	Var. 1 gen.
4,57 ^INR	+2,93%		-5,77%	+18,70%

22/03	Welcure Drugs & Pharmaceuticals Limited annuncia le dimissioni di Priti Rajesh Kharwar come Direttore aggiuntivo, con effetto dal 28 marzo 2024	CI
15/02	Welcure Drugs & Pharmaceuticals Limited annuncia le dimissioni del Consiglio di amministrazione	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024	22/03
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO	16/02
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations	15/02
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer	15/02
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director	15/02
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes	15/02
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director	15/02
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer	15/02
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office	14/02
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address	14/11
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes	14/11
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director	30/10/23
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes	30/09/23
Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Registered Office Within the Local Limits of City of Delhi	04/09/23
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	11/07/23
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	08/10/22
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022	08/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Welcure Drugs & Pharmaceuticals Limited

Azioni

WELCURE6

INE331C01017

Altre lingue

Filtri